Neelam PB, Mekala D, Patel R, Banerjee R, et al. Efficacy and Safety of Vedolizumab and Tofacitinib (VETO) Combination Therapy in Refractory Ulcerative Colitis Unresponsive to Anti-TNF and a Second-Line Advanced Therapy: A Prospective Cohort Nested Within a Randomised Trial. Aliment Pharmacol Ther 2025 Aug 4. doi: 10.1111/apt.70309.
PMID: 40755085